September 2022 "Research on cancer therapies focuses on processes such as angiogenesis, cell signaling , stemness, metastasis, and drug resistance and inflammation, all of which are influenced by the cellular Moreover, the use of propranolol in combination therapies with other drugs has shown synergistic antitumor This review highlights the clinical trials in which propranolol is taking part as adjuvant therapy at

October 2022 Novel Therapies for Cardiometabolic Disease: Recent Findings in Studies with Hormone Peptide-Derived Great success has been reached with therapies based on the GLP-1 receptor monoagonism; therefore, a logical

Nevertheless, researchers have a host of new technologies at their disposal to develop targeted therapies

gynecological malignancies, primarily due to the lack of early diagnostic tools, effective targeted therapy Results show that the elevated expression of UCA1 enhances cell proliferation, invasive migration, and therapy resistance in high-grade serous ovarian carcinoma cells, whereas silencing UCA1 reverses these oncogenic UCA1 expression inversely correlates with survival outcomes and therapy response in ovarian cancer clinical Resistance , UCA1 , lncRNA Source Contribute to the GPCR News Coming soon Become a Contributor Classified

GPCR News < GPCRs in Oncology and Immunology Comparison of infectious complications with BCMA-directed therapies in multiple myeloma Published date May 31, 2024 Abstract "B-cell-maturation-antigen (BCMA)-directed therapies analysis we evaluated infectious complications after BCMA-targeted chimeric-antigen-receptor T-cell therapy Comparing T-cell redirecting therapies, the incidence rate of severe infections was significantly lower

Oncology and Immunology Olfactory Receptors and Tumorigenesis: Implications for Diagnosis and Targeted Therapy The potential for precise tumor diagnosis and targeted therapy through therapeutic targeting of olfactory